Myriad Genetics Inc (MYGN)
19.47
+0.25
(+1.30%)
USD |
NASDAQ |
May 03, 16:00
19.46
-0.01
(-0.05%)
After-Hours: 20:00
Myriad Genetics Revenue (Quarterly): 196.60M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 196.60M |
| September 30, 2023 | 191.90M |
| June 30, 2023 | 183.50M |
| March 31, 2023 | 181.20M |
| December 31, 2022 | 177.80M |
| September 30, 2022 | 156.40M |
| June 30, 2022 | 179.30M |
| March 31, 2022 | 164.90M |
| December 31, 2021 | 160.80M |
| September 30, 2021 | 167.30M |
| June 30, 2021 | 189.40M |
| March 31, 2021 | 173.10M |
| September 30, 2020 | 145.20M |
| June 30, 2020 | 93.20M |
| March 31, 2020 | 164.00M |
| December 31, 2019 | 195.10M |
| September 30, 2019 | 186.30M |
| June 30, 2019 | 215.40M |
| March 31, 2019 | 216.60M |
| December 31, 2018 | 216.80M |
| September 30, 2018 | 202.30M |
| June 30, 2018 | 193.90M |
| March 31, 2018 | 183.10M |
| December 31, 2017 | 187.90M |
| September 30, 2017 | 178.80M |
| Date | Value |
|---|---|
| June 30, 2017 | 157.80M |
| March 31, 2017 | 196.90M |
| December 31, 2016 | 196.50M |
| September 30, 2016 | 177.50M |
| June 30, 2016 | 173.10M |
| March 31, 2016 | 190.50M |
| December 31, 2015 | 193.30M |
| September 30, 2015 | 183.50M |
| June 30, 2015 | 189.90M |
| March 31, 2015 | 180.00M |
| December 31, 2014 | 184.40M |
| September 30, 2014 | 168.80M |
| June 30, 2014 | 188.75M |
| March 31, 2014 | 182.92M |
| December 31, 2013 | 204.06M |
| September 30, 2013 | 202.47M |
| June 30, 2013 | 174.15M |
| March 31, 2013 | 156.47M |
| December 31, 2012 | 149.14M |
| September 30, 2012 | 133.44M |
| June 30, 2012 | 132.96M |
| March 31, 2012 | 129.78M |
| December 31, 2011 | 122.81M |
| September 30, 2011 | 110.45M |
| June 30, 2011 | 107.41M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
93.20M
Minimum
Jun 2020
215.40M
Maximum
Jun 2019
173.41M
Average
178.55M
Median
Revenue (Quarterly) Benchmarks
| Stryker Corp | 5.243B |
| Perspective Therapeutics Inc | -5.239M |
| Electromed Inc | 13.69M |
| Xtant Medical Holdings Inc | 28.11M |
| Asensus Surgical Inc | 5.431M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.20M |
| Total Expenses (Quarterly) | 115.20M |
| EPS Diluted (Quarterly) | -0.36 |
| Enterprise Value | 1.647B |
| Gross Profit Margin (Quarterly) | 68.67% |
| Profit Margin (Quarterly) | -15.87% |
| Earnings Yield | -16.44% |
| Normalized Earnings Yield | -9.958 |